275 related articles for article (PubMed ID: 17941281)
1. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways.
Negri J; Early SB; Steinke JW; Borish L
J Allergy Clin Immunol; 2008 May; 121(5):1232-7. PubMed ID: 18355910
[TBL] [Abstract][Full Text] [Related]
3. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells.
Sjöström M; Johansson AS; Schröder O; Qiu H; Palmblad J; Haeggström JZ
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e37-41. PubMed ID: 12816881
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes.
Lamoureux J; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 Apr; 117(4):924-30. PubMed ID: 16630953
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta.
Asakura T; Ishii Y; Chibana K; Fukuda T
J Allergy Clin Immunol; 2004 Aug; 114(2):310-5. PubMed ID: 15316508
[TBL] [Abstract][Full Text] [Related]
6. IL-18 accelerates the cell apoptosis by up-regulating cysteinyl leukotriene 2 receptor expression in human umbilical vein endothelial cells at the early stage of administration.
Zhou G; Zhou Z; Ge S; Liu D; Zhang R; Xu G; Zhu W; Yin Q; Chen AF; Liu X
Vascul Pharmacol; 2009; 50(5-6):171-7. PubMed ID: 19563734
[TBL] [Abstract][Full Text] [Related]
7. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages.
Thivierge M; Stanková J; Rola-Pleszczynski M
J Immunol; 2001 Sep; 167(5):2855-60. PubMed ID: 11509632
[TBL] [Abstract][Full Text] [Related]
8. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients.
Fujii M; Tanaka H; Abe S
Chest; 2005 Nov; 128(5):3148-55. PubMed ID: 16304255
[TBL] [Abstract][Full Text] [Related]
10. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells.
Yudina Y; Parhamifar L; Bengtsson AM; Juhas M; Sjölander A
Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):223-31. PubMed ID: 19042113
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin.
Chibana K; Ishii Y; Asakura T; Fukuda T
J Immunol; 2003 Apr; 170(8):4290-5. PubMed ID: 12682264
[TBL] [Abstract][Full Text] [Related]
14. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R.
Mellor EA; Frank N; Soler D; Hodge MR; Lora JM; Austen KF; Boyce JA
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11589-93. PubMed ID: 13679572
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts.
Yoshisue H; Kirkham-Brown J; Healy E; Holgate ST; Sampson AP; Davies DE
J Allergy Clin Immunol; 2007 Jan; 119(1):132-40. PubMed ID: 17208594
[TBL] [Abstract][Full Text] [Related]
17. CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression.
Thompson C; Cloutier A; Bossé Y; Thivierge M; Gouill CL; Larivée P; McDonald PP; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):697-704. PubMed ID: 16809637
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
Yu SY; Zhang XY; Wang XR; Xu DM; Chen L; Zhang LH; Fang SH; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2014 Jan; 35(1):33-40. PubMed ID: 24141567
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene D4 accelerates antigen-mediated mast cell responses via the cysteinyl leukotriene 1 receptor.
Fujisawa S; Nagata Y; Suzuki R
Cell Immunol; 2022 Dec; 382():104632. PubMed ID: 36274438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
